Prognostic value of temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis DOI Creative Commons
Yanwu Yang,

Ming Yang,

Yiwu Zhou

et al.

Nutrition, Journal Year: 2023, Volume and Issue: 112, P. 112077 - 112077

Published: May 10, 2023

Sarcopenia has been identified as a prognostic factor among certain types of cancer. However, it is unclear whether there value temporalis muscle thickness (TMT), potential surrogate for sarcopenia, in adults patients with brain tumors. Therefore, we searched the Medline, Embase, and PubMed to systematically review meta-analyze relationship between TMT overall survival, progression-free complications tumors hazard ratio (HR) or odds ratios (OR), 95% confidence interval (CI) were evaluated. The quality studies (QUIPS) instrument was employed evaluate study quality. Nineteen involving 4570 included qualitative quantitative analysis. Meta-analysis revealed thinner associated poor survival (HR, 1.72; CI, 1.45–2.04; P < 0.01) Sub-analyses showed that association existed both primary 2.02; 1.55-2.63) metastases 1.39; 1.30-1.49). Moreover, also independent predictor 2.88; 1.85–4.46; 0.01). improve clinical decision making important integrate assessment into routine settings

Language: Английский

Standard values for temporal muscle thickness in the Japanese population who undergo brain check-up by magnetic resonance imaging DOI Creative Commons
Masahito Katsuki, Norio Narita, Keisuke Sasaki

et al.

Surgical Neurology International, Journal Year: 2021, Volume and Issue: 12, P. 67 - 67

Published: Feb. 23, 2021

Background: Skeletal muscle mass is an important factor for various diseases’ outcomes. The psoas cross-sectional area on the abdominal computed tomography (CT), gait speed, and handgrip strength used to measure it. However, it difficult neurological patients’ or function because (1) we do not perform CT. (2) Such patients have impaired consciousness, disturbance, paresis, need of rest. Temporal thickness (TMT) magnetic resonance imaging (MRI) now attractive skeletal volume indicator, but reference values are established. We herein investigated standard value Japanese TMT using brain check-up database by MRI. Methods: retrospectively 360 individuals from two institutions between 2017 2019. measured T1-weighted images in previously reported way. associations other variables were analyzed. Results: 214 women 146 men, ranging 35 84 years old, was investigated. ranged 3.69 16.90 mm. Mean significantly higher men compared except over 70-year-old cohort. correlated weight body index both sexes. Conclusion: This first retrospective study database. Our results just values, these would be useful further investigation neurosurgical diseases regarding sarcopenia.

Language: Английский

Citations

12

Temporal Muscle Thickness is an Independent Prognostic Biomarker in Patients with Glioma: Analysis of 261 Cases DOI Creative Commons

Ou Ying Yan,

Hai Bo Teng,

Sheng Nan Fu

et al.

Cancer Management and Research, Journal Year: 2021, Volume and Issue: Volume 13, P. 6621 - 6632

Published: Aug. 1, 2021

Temporal muscle thickness (TMT) has been proposed as a novel surrogate marker for skeletal mass in head and neck malignancies. This study investigated the TMT prognostic relevance with gliomas evaluated influence of values on survival patients different grades IDH subtypes.The patients' was measured contrast-enhanced T1-weighted magnetic resonance images before surgical treatment. Patients were divided into two cohorts based their median values. The Kaplan-Meier curve used to compute overall (OS) categories all gliomas. Univariate multivariate Cox regression analyses conducted assess association between OS TMT, hematological markers, other clinical factors glioma patients. Moreover, diagnostic efficiency single combination biomarkers using receiver operating characteristic analysis.We retrospectively analyzed 261 newly diagnosed November 2016 May 2020 at Hunan Cancer Hospital. analysis indicated that higher (HR 0.286, P< 0.001) KPS score 0.629, P= 0.012) protective wildtype status 2.946, 0.001), RDW > 12.6 1.513, 0.036), NLR 4 1.560, 0.042) poor Subsequently, thicker found have significantly better (P<0.001) than thinner among WHO III IV grade or without mutation. considered biomarker recently prevalent predicting high-grade [0.856 (0.797-0.916)] IDH- wild-type [0.864 (0.786-0.941)] gliomas.This suggests is positive prognosis greater subtypes.

Language: Английский

Citations

12

Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson’s Disease DOI
Seok Jong Chung, Yun Joong Kim, Han Soo Yoo

et al.

The Journals of Gerontology Series A, Journal Year: 2021, Volume and Issue: 76(12), P. 2242 - 2248

Published: March 23, 2021

To investigate the relationship between temporalis muscle thickness (TMT) at baseline as a surrogate marker for sarcopenia and long-term motor outcomes in patients with Parkinson's disease (PD).We enrolled 249 drug-naïve early-stage PD (119 males 130 females, follow-up > 3 years). Baseline TMT of each patient was measured on axial plane T1-weighted images. The association assessed using Cox regression models levodopa-induced dyskinesia, wearing-off, freezing gait linear mixed model longitudinal increases levodopa-equivalent dose per body weight over time. Statistical analyses were performed separately sex if an interaction effect assumed.TMT differed substantially sexes, male had higher (6.69 ± 1.39 mm) than female (5.64 1.34 mm, p < .001). demonstrated that not associated risk developing or during period. applied slower patients, but patients.This study could be indicator requirement dopaminergic medications PD, suggesting may have detrimental progression sex-specific manner.

Language: Английский

Citations

11

Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients DOI Creative Commons
Fabian M. Troschel,

Benjamin O. Troschel,

Maren Kloss

et al.

Clinical and Translational Radiation Oncology, Journal Year: 2023, Volume and Issue: 40, P. 100621 - 100621

Published: March 27, 2023

Glioblastoma (GBM) patients face a strongly unfavorable prognosis despite multimodal therapy regimens. However, individualized mortality prediction remains imprecise. Harnessing routine radiation planning cranial computed tomography (CT) scans, we assessed cervical body composition measures as novel biomarkers for overall survival (OS) in GBM patients.We performed threshold-based semi-automated quantification of muscle and subcutaneous fat cross-sectional area (CSA) at the levels first second vertebral body. First, tested this method's validity by correlating to established abdominal an open-source whole-body CT cohort. We then identified consecutive undergoing recent diagnosis our institution from 2010 2020 quantified on scans. Finally, univariable multivariable time-to-event analyses, adjusting age, sex, mass index, comorbidities, performance status, extent surgical resection, tumor diagnosis, MGMT methylation.Cervical measurements were well-correlated with markers (Spearman's rho greater than 0.68 all cases). Subsequently, included 324 study cohort (median age 63 years, 60.8% male). 293 (90.4%) died during follow-up. Median time was 13 months. Patients below-average CSA or above-average demonstrated shorter survival. In continuous remained independently associated OS.This exploratory establishes routinely available scans confirms their association OS diagnosed GBM.

Language: Английский

Citations

4

Prognostic value of temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis DOI Creative Commons
Yanwu Yang,

Ming Yang,

Yiwu Zhou

et al.

Nutrition, Journal Year: 2023, Volume and Issue: 112, P. 112077 - 112077

Published: May 10, 2023

Sarcopenia has been identified as a prognostic factor among certain types of cancer. However, it is unclear whether there value temporalis muscle thickness (TMT), potential surrogate for sarcopenia, in adults patients with brain tumors. Therefore, we searched the Medline, Embase, and PubMed to systematically review meta-analyze relationship between TMT overall survival, progression-free complications tumors hazard ratio (HR) or odds ratios (OR), 95% confidence interval (CI) were evaluated. The quality studies (QUIPS) instrument was employed evaluate study quality. Nineteen involving 4570 included qualitative quantitative analysis. Meta-analysis revealed thinner associated poor survival (HR, 1.72; CI, 1.45–2.04; P < 0.01) Sub-analyses showed that association existed both primary 2.02; 1.55-2.63) metastases 1.39; 1.30-1.49). Moreover, also independent predictor 2.88; 1.85–4.46; 0.01). improve clinical decision making important integrate assessment into routine settings

Language: Английский

Citations

4